While you raise valid point about the RC220, there must be a reason the mgmt and scientists thought this would work based on the physical and chemical properties of RC220 vs RC110? Where in the process would we confirm this before it is injected into patients?
Given that RC220 is the biggest dependency/ bottleneck for Race's progress fingers-crossed that RC220 works, if not we are like MSB... back to the drawing board and another couple of years of wait time... let's hope not!
Ann: Race Board and Management Team Changes, page-442
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.000(0.00%) |
Mkt cap ! $270.9M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.62 | $1.55 | $189.9K | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1316 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 34961 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |